Rising Teen Marijuana Abuse Outpaces Alcohol Decline: Study

Dec.05.2022
Rising Teen Marijuana Abuse Outpaces Alcohol Decline: Study
Marijuana abuse among US youths has increased by 245% since 2000, while alcohol abuse has steadily declined.

Since 2000, there has been a 245% increase in marijuana abuse among American teenagers, while alcohol abuse has steadily declined during the same period.


According to a nationally peer-reviewed study, intentional abuse and misuse reported to the National Poison Data System (NPDS) were tracked through the year 2020.


The investigation results published today in the peer-reviewed journal "Clinical Toxicology" have found that there were over 338,000 incidents of intentional abuse or misuse in American children aged 6 to 18 years old.


Most of the cases occurred in males (58.3%), with over 80% of all reported cases of exposure occurring in young individuals aged between 13 and 18. Overall, more than 32% of instances resulted in clinical outcomes worse than minor.


A new report has revealed changes in patterns over time. For instance, during the research period, Ritalin was the substance with the most reported use, but it peaked in 2006 and has since declined.


Furthermore, the year 2000 had the highest number of abuse cases involving contact with ethanol, but since then, incidents of children drinking alcohol have steadily declined over the years.


In contrast, cases of marijuana exposure remained relatively stable from the year 2000 to 2009 and then began to steadily increase from 2011 onwards, with an even greater increase in cases observed from the years 2017 to 2020.


Experts analyzing data attribute the increase in marijuana use to the growing popularity of edible marijuana products, which are now widely used throughout the country.


According to Dr. Adrienne Hughes, an assistant professor of emergency medicine at Oregon Health & Science University and one of the authors of the study, from 2000 to 2013, the number of cases of ethanol abuse exceeded the number of cases involving marijuana each year.


However, by 2014, this trend had reversed.


Since 2014, cases of exposure to marijuana have exceeded cases of exposure to alcohol every year, and the numbers have been increasing each year," said Hughes.


Though all rates of marijuana abuse are on the rise, the average monthly growth rate of marijuana consumption is the highest when compared with all other forms. This indicates that teenagers have shifted from smoking marijuana to other methods of consumption. Marijuana extracts, such as those used in marijuana electronic cigarette products, are also increasingly popular.


Hughes said, "These edible and electronic vaping products are typically marketed in a way that appeals to young people and are considered more independent and convenient.


Nevertheless, despite being perceived as having minimal harm, studies indicate that this is not necessarily the case.


According to Hughes, "While smoking marijuana typically leads to an immediate high, consuming it in an edible form can take several hours to take effect, which may cause some people to consume more and experience unexpected and unpredictable highs.


Since 2017, there has been a sharp increase in the number of children using marijuana, coinciding with a wave of decriminalization legislation in the United States. As of 2022, marijuana is legal for adult recreational use in 19 states and legal for medical use in 36 states.


Although marijuana is only legal for adults and not for children, the authors of this study argue that it makes it easier for children and adolescents to come into contact with the drug, and leads people to believe that it is safe.


Our research describes the rising trend of adolescent marijuana abuse, particularly those involving edible products," said Hughes.


These survey results highlight continued concern among people about the impact of rapid marijuana legalization on this vulnerable population.


In addition to marijuana, the study also revealed cases of teenage abuse of non-prescription drugs. Between 2001 and 2016, the highest number of drug abuse cases were related to dextromethorphan, a non-prescription cold and cough medication. Oral antihistamines were also among the most commonly abused drugs in this study.


Deaths caused by drug abuse are rare, occurring in only 0.1% of cases among 450 young people. The incidence of death is higher among males and teenagers aged 16-18. Opioids are most commonly associated with these deaths.


Furthermore, although there were 57,488 incidents involving children aged 6 to 12, these cases typically do not involve "traditional" drugs but rather vitamins, plants, melatonin, hand sanitizer, and other items.


The limitations of this study are restricted to exposure cases categorized as abuse or misuse. "It is possible that other cases of misuse or abuse may have been classified in another manner and therefore missed," the authors report.


2FIRSTS will continue to follow and report on this topic. Further updates will be posted on the '2FIRSTS APP'. Scan the QR code below to download the app.



Disclaimer

This article is provided solely for professional research, industry discussion, and informational purposes. Any references to brands, companies, products, technologies, or policies are made for factual reporting and analytical purposes only, and do not constitute endorsement, recommendation, promotion, or advertising by 2Firsts.

Nicotine-containing products, including but not limited to cigarettes, e-cigarettes, heated tobacco products, and nicotine pouches, carry significant health risks. Readers are responsible for complying with all applicable laws and regulations in their respective jurisdictions, including age restrictions and access limitations.

The information contained in this article should not be regarded as investment, legal, medical, regulatory, or commercial advice. While 2Firsts strives to ensure the accuracy and reliability of its content, it does not assume liability for any direct or indirect loss arising from errors, omissions, inaccuracies, or reliance on the information contained herein.

This article is not intended for individuals below the legal age for accessing tobacco or nicotine-related information in their jurisdiction.

 

Copyright Notice

This article is either original content produced by 2Firsts or content reproduced, translated, summarized, or adapted from third-party sources with attribution where applicable. The intellectual property rights of the original content remain with 2Firsts or the respective original rights holders.

No individual or organization may copy, reproduce, distribute, republish, modify, translate, or otherwise use this content without prior authorization. Any unauthorized use may result in legal action.

For copyright-related inquiries, corrections, or removal requests, please contact: info@2firsts.com.

 

AI-Assisted Translation and Editing Notice

Portions of this article may have been translated, edited, or reviewed with the assistance of artificial intelligence tools to improve efficiency and readability. Due to the limitations of AI-assisted translation and editing, discrepancies, omissions, or inaccuracies may exist when compared with the original source.

Where applicable, readers are advised to refer to the original source for the most complete and accurate information. If you identify any errors or believe that any content infringes upon your rights, please contact us at info@2firsts.com, and we will review and address the matter promptly.

JUUL Purchasers Ask Ninth Circuit to Preserve Antitrust Classes in Case Over Altria’s $12.8 Billion Investment
JUUL Purchasers Ask Ninth Circuit to Preserve Antitrust Classes in Case Over Altria’s $12.8 Billion Investment
Private antitrust litigation stemming from Altria's 2018 $12.8 billion investment for a 35% economic interest in JUUL is advancing before the U.S. Court of Appeals for the Ninth Circuit. Direct purchasers, indirect purchasers and indirect resellers of JUUL products filed answering briefs this week seeking to preserve class certifications granted by a California federal court in February. Altria and JUUL argue that individual consumers and large distributors differ too much in purchasing terms to remain in a single direct-purchaser class, while a separate dispute concerns whether California antitrust law can apply to indirect purchasers across 27 jurisdictions. A September trial has been put on hold during the appeal.
Sep.23
Product | SMOORE's VAPORESSO Introduces VAST Refillable Vape With Three Resistances in One Pod
Product | SMOORE's VAPORESSO Introduces VAST Refillable Vape With Three Resistances in One Pod
SMOORE-owned vaping brand VAPORESSO introduced the VAST refillable open-system vape in October 2026, featuring Tri-Core Mesh technology that integrates three resistance configurations—0.8Ω, 0.6Ω and 0.4Ω—within a single pod. The device supports different operating modes and e-liquid types. The standard version features a 10mL pod, while a TPD-labelled configuration combines a 2mL pod with an 8mL refill container. The device has a 1,600mAh battery and a maximum output of 30W. VAPORESSO claims up to six pod refills and a tested coil lifespan of up to 150,000 puffs. The UK's MHRA published a related device notification on October 12. The official MSRP is $25.90, compared with a $35.90 listing on VAPORESSO's direct store.
product
Oct.30
UK Directors Banned After 352,688 Vapes Imported From China Were Misdeclared as Medical Nebulizers in £15 Million Tax Case
UK Directors Banned After 352,688 Vapes Imported From China Were Misdeclared as Medical Nebulizers in £15 Million Tax Case
The UK Insolvency Service said YSK Enterprises imported large quantities of vapes from China in 2023, with a shipment addressed to the company declared as medical nebulizers before Border Force found 352,688 vaping products. HMRC calculated nearly £15 million ($20.3 million) in unpaid VAT and customs duty, alongside about £437,000 in corporation tax. Two directors were disqualified for nine years. The case predates the UK's Vaping Products Duty, which will introduce vape-specific excise and duty-stamp requirements from October 2026.
Regulations
Sep.11
Canada Health Minister Says She Is Not Considering Looser Nicotine Pouch Retail Rules as PMI-Linked Group Pushes for Wider Access
Canada Health Minister Says She Is Not Considering Looser Nicotine Pouch Retail Rules as PMI-Linked Group Pushes for Wider Access
Canadian Health Minister Marjorie Michel says she is not considering loosening retail restrictions on nicotine pouches. Canada regulates pouches containing 4 mg or less of nicotine per unit as non-prescription nicotine replacement therapy and requires newer NRT formats such as pouches to be sold from behind pharmacy counters. Meanwhile, Unsmoke Canada, linked to Philip Morris International's Canadian business, is pushing to allow pouches in convenience stores and other general retail outlets. Health Canada also acknowledges continued unauthorized sales, while recent research shows rising pouch use among Canadian youth aged 16 to 19.
Sep.24
Smoore Seeks to Toss CCELL Price-Fixing Claim as Court Weighs Vertical Distribution Versus Horizontal Conspiracy
Smoore Seeks to Toss CCELL Price-Fixing Claim as Court Weighs Vertical Distribution Versus Horizontal Conspiracy
Smoore and four authorized U.S. CCELL distributors are asking a California federal court to permanently dismiss a core antitrust claim brought by direct purchasers. Plaintiffs allege that Smoore coordinated minimum wholesale prices, customer allocation and limits on price competition among distributors, amounting to a per se unlawful horizontal conspiracy. The defendants say the alleged conduct reflects ordinary vertical relationships between a manufacturer and its distributors. The court previously dismissed a similar claim, and the latest dispute centers on whether the second amended complaint adds sufficient facts to establish a horizontal agreement.
Sep.14
Philip Morris Malaysia Again Meets Religious Authority Over Cigarette Alternatives as Perlis Mufti Responds on Halal Criteria
Philip Morris Malaysia Again Meets Religious Authority Over Cigarette Alternatives as Perlis Mufti Responds on Halal Criteria
Philip Morris Malaysia Managing Director Naeem Shahab Khan met Perlis Mufti Mohd Asri Zainul Abidin on September 17 and presented the company's shift from conventional cigarettes toward alternative products. The mufti said a product could be considered halal if it is clean, its side effects are not harmful or can be controlled, and it does not involve excessive waste. His remarks did not mention IQOS or any other specific PMI product and did not amount to a new product-specific religious ruling. It was at least the second publicly reported engagement between Philip Morris Malaysia and a Malaysian religious institution over cigarette alternatives within six months.
Regulations
Sep.18 by 2Firsts Perspectives